#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3232	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2413	397.7	0	.	n	.	0	A69G	SNP	69	69	A	508	508	G	466	G,A,T	282,102,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3232	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2413	397.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1889	1889	T	453	T,G,A	383,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3232	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2413	397.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1623	1623	C	534	C,G	430,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4004	414.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1920	1920	A	450	A,T,C	365,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4004	414.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2554	2554	C	528	C,A,T	431,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4004	414.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2628	2628	A	583	A	459	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4004	414.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3180	3180	C	494	C	398	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	506	folP	852	852	99.88	folP.l6.c4.ctg.1	1907	79.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	954	956	AAA	102;102;103	A;A;A,C	84;81;86,1	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	506	folP	852	852	99.88	folP.l6.c4.ctg.1	1907	79.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1185	1187	AGC	103;103;103	A;G;C,A	79;83;82,1	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	956	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3679	77.7	1	SNP	p	S91F	0	.	.	271	273	TCC	636	638	TCC	72;72;72	T;C,A;C	57;57,1;59	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	956	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3679	77.7	1	SNP	p	D95G	0	.	.	283	285	GAC	648	650	GAC	76;76;75	G;A;C	62;63;61	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	956	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3679	77.7	1	SNP	p	D95N	0	.	.	283	285	GAC	648	650	GAC	76;76;75	G;A;C	62;63;61	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	496	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1756	84.4	1	SNP	p	G45D	0	.	.	133	135	GGC	676	678	GGC	163;163;162	G;G;C	130;131;132	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	274	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1631	49.9	0	.	n	.	0	A197.	DEL	197	197	A	856	856	A	130	A,C	101,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1144	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	102.0	1	SNP	p	D86N	0	.	.	256	258	GAC	790	792	GAC	137;137;136	G;A;C	113;108;113	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1144	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	102.0	1	SNP	p	S87R	0	.	.	259	261	AGT	793	795	AGT	133;133;133	A,C;G;T	107,1;106;106	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1144	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	102.0	1	SNP	p	S87I	0	.	.	259	261	AGT	793	795	AGT	133;133;133	A,C;G;T	107,1;106;106	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1144	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	102.0	1	SNP	p	S87W	0	.	.	259	261	AGT	793	795	AGT	133;133;133	A,C;G;T	107,1;106;106	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1144	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	102.0	1	SNP	p	S88P	0	.	.	262	264	TCC	796	798	TCC	133;133;133	T;C,G;C	106;107,1;113	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	972	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3064	95.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1736	1738	GGC	135;135;134	G,T;G,T;C,A	107,1;107,1;102,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1377	1379	GCA	134;134;133	G;C,A;A,C	108;106,1;111,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1380	1382	ATC	133;132;132	A,C;T;C	110,1;104;107	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1392	1394	GTG	138;138;139	G;T;G	111;106;114	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1392	1394	GTG	138;138;139	G;T;G	111;106;114	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1896	1898	ACC	110;110;109	A,C;C;C	84,2;90;95	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1950	1952	GCG	100;99;99	G;C,G;G	78;75,2;77	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1950	1952	GCG	100;99;99	G;C,G;G	78;75,2;77	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2073	2075	GGC	100;99;98	G,A,C;G;C	86,1,1;86;83	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2082	2084	GGC	98;99;100	G;G,A;C	84;80,1;87	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	884	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2802	94.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2100	2102	CTG	96;99;101	C;T;G	80;84;85	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1150	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3425	100.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1844	1846	CCG	92;91;90	C;C;G	76;77;77	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	596	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2132	83.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	749	749	C	89	C	71	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	H217N	NONSYN	649	651	CAT	792	794	AAT	8;8;8	A;A;T	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	D218N	NONSYN	652	654	GAT	795	797	AAT	8;8;8	A;A;T	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	V226A	NONSYN	676	678	GTA	819	821	GCA	7;7;7	G;C;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	.	MULTIPLE	700	702	ACT	842	844	GTA	5;5;5	G;T;A	5;5;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	S236N	NONSYN	706	708	AGC	848	850	AAC	5;5;5	A;A;C	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	.	MULTIPLE	709	711	AAC	852	856	TGGCG	5;5;5;5;5	T;G;G;C;G	5;5;4;4;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	D238A	NONSYN	712	714	GAT	858	860	GCT	5;5;5	G;C;T	4;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	918	920	TTA	5;5;5	T;T;A	4;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	963	965	CAT	5;5;5	C;A;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	966	968	AGT	5;5;5	A;G;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	287	90.38	porB1a.l6.c17.ctg.1	1055	12.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	975	977	TAC	5;6;6	T;A;C	5;5;5	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	534	536	GAA	144;144;144	G;A;A	115;114;115	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	822	824	GAT	108;108;108	G,T;A,C;T	86,1;86,1;85	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	945	947	TCA	118;118;118	T;C;A	96;94;97	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1074	1076	GTC	139;139;138	G;T;C	114;114;111	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1086	1088	TCT	140;139;139	T;C,T;T,G,A	109;113,1;112,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	0	.	p	.	0	V223I	NONSYN	667	669	GTT	1089	1091	ATT	139;139;138	A,G;T;T	116,1;114;118	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1404	1406	GCA	149;149;148	G;C;A,G	125;126;119,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	1	SNP	p	G120K	1	.	.	358	360	AAG	780	782	AAG	116;115;113	A;A;G	95;91;94	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	1	SNP	p	D121N	0	.	.	361	363	GAC	783	785	GAC	113;114;115	G,A;A;C	92,1;97;95	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	658	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2288	85.1	1	SNP	p	A121D	1	.	.	361	363	GAC	783	785	GAC	113;114;115	G,A;A;C	92,1;97;95	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2308	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5043	136.8	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2111	2113	AAT	128;128;128	A;A;T	104;105;104	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	354	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1412	75.0	1	SNP	p	V57M	1	.	.	169	171	ATG	660	662	ATG	143;142;143	A;T;G	114;115;115	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
